Literature DB >> 30272503

Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.

David J Feller-Kopman, Chakravarthy B Reddy, Malcolm M DeCamp, Rebecca L Diekemper, Michael K Gould, Travis Henry, Narayan P Iyer, Y C Gary Lee, Sandra Z Lewis, Nick A Maskell, Najib M Rahman, Daniel H Sterman, Momen M Wahidi, Alex A Balekian.   

Abstract

BACKGROUND: This Guideline, a collaborative effort from the American Thoracic Society, Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence-based recommendations to guide contemporary management of patients with a malignant pleural effusion (MPE).
METHODS: A multidisciplinary panel developed seven questions using the PICO (Population, Intervention, Comparator, and Outcomes) format. The GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach and the Evidence to Decision framework was applied to each question. Recommendations were formulated, discussed, and approved by the entire panel.
RESULTS: The panel made weak recommendations in favor of: 1) using ultrasound to guide pleural interventions; 2) not performing pleural interventions in asymptomatic patients with MPE; 3) using either an indwelling pleural catheter (IPC) or chemical pleurodesis in symptomatic patients with MPE and suspected expandable lung; 4) performing large-volume thoracentesis to assess symptomatic response and lung expansion; 5) using either talc poudrage or talc slurry for chemical pleurodesis; 6) using IPC instead of chemical pleurodesis in patients with nonexpandable lung or failed pleurodesis; and 7) treating IPC-associated infections with antibiotics and not removing the catheter.
CONCLUSIONS: These recommendations, based on the best available evidence, can guide management of patients with MPE and improve patient outcomes.

Entities:  

Keywords:  malignant; palliation; pleural catheter; pleural effusion; pleurodesis

Mesh:

Substances:

Year:  2018        PMID: 30272503     DOI: 10.1164/rccm.201807-1415ST

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  53 in total

1.  Pleural Disease Management: Manometry-guided Thoracentesis, Optimal Drainage Regimen of Indwelling Pleural Catheters, and Talc Poudrage versus Slurry for Malignant Pleural Effusion.

Authors:  Andrea Mytinger; Trevor Taylor; Evgeni Gershman; Samira Shojaee
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

Review 2.  Contemporary approach to the patient with malignant pleural effusion complicating lung cancer.

Authors:  Oleg Epelbaum; Najib M Rahman
Journal:  Ann Transl Med       Date:  2019-08

3.  Pleural Diseases: Pleurodesis via Indwelling Pleural Catheter, Dasatinib-induced Pleural Effusion, and IL-27 in Tuberculosis Pleural Effusion.

Authors:  Ala-Eddin S Sagar; Daniel L Dodge; Moiz Salahuddin; Mark T Warner; Garbo Mak; Saadia A Faiz
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

4.  Diagnostic value of periostin in lung cancer-related malignant pleural effusion.

Authors:  Jinjin Zhang; Tongtong Zha; Na Zhang; Gengyun Sun
Journal:  J Clin Lab Anal       Date:  2021-12-27       Impact factor: 2.352

5.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

6.  Application of autologous blood patch in patients with non-expanded lungs and persistent air leak.

Authors:  Burhan Apilioğulları; Ahmet Dumanlı; Sami Ceran
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-07-28       Impact factor: 0.332

7.  Hemorrhagic Malignant Pleural Effusion: Diagnosis, Survival Rate, and Response to Talc Pleurodesis.

Authors:  Gadi Lending; Yousef Abed El Ghani; Edward Kaykov; Boris Svirsky; Hector Isaac Cohen; Edward Altman
Journal:  Indian J Surg Oncol       Date:  2020-11-14

8.  Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation.

Authors:  Rachelle Asciak; Nikolaos I Kanellakis; Xuan Yao; Megat Abd Hamid; Rachel M Mercer; Maged Hassan; Eihab O Bedawi; Melissa Dobson; Peter Fsadni; Stephen Montefort; Tao Dong; Najib M Rahman; Ioannis Psallidas
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

9.  Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.

Authors:  Sofia Molina; Gabriela Martinez-Zayas; Paula V Sainz; Cheuk H Leung; Liang Li; Horiana B Grosu; Roberto Adachi; David E Ost
Journal:  Chest       Date:  2021-05-11       Impact factor: 10.262

10.  Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.

Authors:  Audra J Schwalk; David E Ost; Sahara N Saltijeral; Henriette De La Garza; Roberto F Casal; Carlos A Jimenez; Georgie A Eapen; Jeff Lewis; Waree Rinsurongkawong; Vadeerat Rinsurongkawong; Jack Lee; Yasir Elamin; Jianjun Zhang; Jack A Roth; Stephen Swisher; John V Heymach; Horiana B Grosu
Journal:  Chest       Date:  2020-11-17       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.